Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Netwerk
Projecten
- 1 Afgelopen
Onderzoeksoutput
-
Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease
Del'Haye, G., Nulmans, I., Bouteille, S. P., Preek, K., Wellekens, B., Rombaut, M., Vanhaecke, T., Vander Heyden, Y. & De Kock, J., 4 aug 2022, In: Archives of Toxicology. 96, 11, blz. 2881-2897 17 blz.Onderzoeksoutput: Article › peer review
-
From NAFLD to MAFLD: Aligning translational in vitro research to clinical insights
Gatzios, A., Rombaut, M., Buyl, K., De Kock, J., Rodrigues, R., Rogiers, V., Vanhaecke, T. & Boeckmans, J., 13 jan 2022, In: Biomedicines. 10, 1, 19 blz., 161.Onderzoeksoutput: Article › peer review
Open AccessBestand52 Downloads (Pure) -
Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells
Fraire, J. C., Shaabani, E., Sharifiaghdam, M., Rombaut, M., Hinnekens, C., Hua, D., Ramon, J., Raes, L., Bolea-Fernandez, E., Brans, T., Vanhaecke, F., Borghgraef, P., Huang, C., Sauvage, F., Vanhaecke, T., De Kock, J., Xiong, R., De Smedt, S. & Braeckmans, K., dec 2022, In: Nature Communications. 13, 1, 16 blz., 1996.Onderzoeksoutput: Article › peer review
Open Access3 Citaten (Scopus) -
Publisher Correction: Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells (Nature Communications, (2022), 13, 1, (1996), 10.1038/s41467-022-29713-7)
Fraire, J. C., Shaabani, E., Sharifiaghdam, M., Rombaut, M., Hinnekens, C., Hua, D., Ramon, J., Raes, L., Bolea-Fernandez, E., Brans, T., Vanhaecke, F., Borghgraef, P., Huang, C., Sauvage, F., Vanhaecke, T., De Kock, J., Xiong, R., De Smedt, S. & Braeckmans, K., 26 apr 2022, In: Nature Communications. 13, 1, 1 blz., 2385.Onderzoeksoutput: Comment/debate
Open Access -
Resmetirom reduces lipid load, restores THRB expression and prevents cell damage in a human stem cell based in vitro MAFLD model.
Gatzios, A., Rodrigues, R., De Kock, J., Verhoeven, A., Sepehri, S., Buyl, K., Rombaut, M., Rogiers, V., Boeckmans, J. & Vanhaecke, T., 10 jun 2022, Resmetirom reduces lipid load, restores THRB expression and prevents cell damage in a human stem cell based in vitro MAFLD model.. 3rd European Fatty Liver Conference, blz. 49-49 1 blz.Onderzoeksoutput: Meeting abstract (Book)
Prijzen
-
HepaSTAR: Hepatogenic programming of human skin-derived precursor cells and their evaluation for liver disease therapy and regeneration.
Rombaut, Matthias (Recipient), 2020
Prijs: Other distinction
Activiteiten
-
Resmetirom reduces lipid load, restores THRB expression and prevents cell damage in a human stem cell based in vitro MAFLD model.
Alexandra Gatzios (Speaker), Robim Marcelino Rodrigues (Contributor), Joery De Kock (Contributor), Anouk Verhoeven (Contributor), Sara Sepehri (Contributor), Karolien Buyl (Contributor), Matthias Rombaut (Contributor), Vera Rogiers (Contributor), Joost Boeckmans (Contributor) & Tamara Vanhaecke (Contributor)
10 jun 2022Activiteit: Talk or presentation at a conference
-
World Advanced Therapies & Regenerative Medicine 2021
Matthias Rombaut (Participant)
1 apr 2021 → 3 apr 2021Activiteit: Participation in conference
-
Programming human somatic cells into hepatocytes for applications in toxicology
Matthias Rombaut (Invited speaker)
16 dec 2021Activiteit: Talk or presentation at a workshop/seminar
-
Direct reprogramming of somatic cells into induced hepatocytes: cracking the Enigma code
Matthias Rombaut (Invited speaker)
15 jun 2021Activiteit: Talk at an external academic organisation
-
Scriptie
-
Evaluatie van de efficiëntie van CRE mRNA-geïnduceerde recombinase in humane huidafgeleide mesenchymale stamcellen.
Auteur: Rombaut, M., Vanhaecke, T., De Kock, J. & Neuckermans, J., 2018Scriptie/Masterproef: Master's Thesis